Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma.
Sainz V, Moura LIF, Peres C, Matos AI, Viana AS, Wagner AM, Vela Ramirez JE, S Barata T, Gaspar M, Brocchini S, Zloh M, Peppas NA, Satchi-Fainaro R, F Florindo H. Sainz V, et al. Among authors: moura lif. Acta Biomater. 2018 Aug;76:193-207. doi: 10.1016/j.actbio.2018.06.029. Epub 2018 Jun 22. Acta Biomater. 2018. PMID: 29940370 Free PMC article.
Regulatory aspects on nanomedicines.
Sainz V, Conniot J, Matos AI, Peres C, Zupancic E, Moura L, Silva LC, Florindo HF, Gaspar RS. Sainz V, et al. Biochem Biophys Res Commun. 2015 Dec 18;468(3):504-10. doi: 10.1016/j.bbrc.2015.08.023. Epub 2015 Aug 8. Biochem Biophys Res Commun. 2015. PMID: 26260323 Review.
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.
Matos AI, Carreira B, Peres C, Moura LIF, Conniot J, Fourniols T, Scomparin A, Martínez-Barriocanal Á, Arango D, Conde JP, Préat V, Satchi-Fainaro R, Florindo HF. Matos AI, et al. Among authors: moura lif. J Control Release. 2019 Aug 10;307:108-138. doi: 10.1016/j.jconrel.2019.06.017. Epub 2019 Jun 19. J Control Release. 2019. PMID: 31226355 Review.
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators.
Conniot J, Scomparin A, Peres C, Yeini E, Pozzi S, Matos AI, Kleiner R, Moura LIF, Zupančič E, Viana AS, Doron H, Gois PMP, Erez N, Jung S, Satchi-Fainaro R, Florindo HF. Conniot J, et al. Among authors: moura lif. Nat Nanotechnol. 2019 Sep;14(9):891-901. doi: 10.1038/s41565-019-0512-0. Epub 2019 Aug 5. Nat Nanotechnol. 2019. PMID: 31384037
Preclinical models and technologies to advance nanovaccine development.
Peres C, Matos AI, Moura LIF, Acúrcio RC, Carreira B, Pozzi S, Vaskovich-Koubi D, Kleiner R, Satchi-Fainaro R, Florindo HF. Peres C, et al. Among authors: moura lif. Adv Drug Deliv Rev. 2021 May;172:148-182. doi: 10.1016/j.addr.2021.03.001. Epub 2021 Mar 9. Adv Drug Deliv Rev. 2021. PMID: 33711401 Review.
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.
Matos AI, Peres C, Carreira B, Moura LIF, Acúrcio RC, Vogel T, Wegener E, Ribeiro F, Afonso MB, Santos FMF, Martínez-Barriocanal Á, Arango D, Viana AS, Góis PMP, Silva LC, Rodrigues CMP, Graca L, Jordan R, Satchi-Fainaro R, Florindo HF. Matos AI, et al. Among authors: moura lif. Adv Sci (Weinh). 2023 Sep;10(25):e2300299. doi: 10.1002/advs.202300299. Epub 2023 Jul 11. Adv Sci (Weinh). 2023. PMID: 37434063 Free PMC article.
19 results